---
$id: https://graph.org.ai/products/commodity/51201827
$type: Product
source: UNSPSC
code: "51201827"
title: "Levamisole hydrochloride"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levamisole hydrochloride

**UNSPSC Code**: 51201827
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a chemo immunostimulant adjuvant with the molecular formula C11H12N2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DL9055K809, chemically known as 2,3,5,6-tetrahydro-6-phenyl-imidazo(2,1-b)thiazole but more generally known as levamisole hydrochloride, which bears US NIH Compound Identifier 3913. European Medicines Agency schedules Levamisole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02902MIG. Most nations, for tariff and trade purposes, schedule levamisole hydrochloride under HS 29349990. As of Q4 2014, LEVAMISOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Levamisole hydrochloride bears US NLM identifiers UMLS ID C0733384 and NCI Concept Code C610. SMILES: C1CCC(CC1)[C@H]2CN3CCSC3=N2.CL.

